Grace Therapeutics grants 267K options to CEO
Grace Therapeutics, Inc. (GRCE) reported that Chief Executive Officer and director Prashant Kohli received a grant of 267,160 stock options on 2026-08-28.
Rhea-AI Filing Summary
Grace Therapeutics, Inc. (GRCE) reported that Chief Executive Officer and director Prashant Kohli received a grant of 267,160 stock options on 2026-08-28. The options have an exercise price of $2.12 per share, expire on 2036-08-27, and relate to 267,160 shares of common stock. According to the vesting terms, 1/12 of the options vested immediately on the grant date and the remaining 11/12 vest in substantially equal quarterly installments over the following 11 quarters, subject to his continuous service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 267,160 shares
Grant/Award
1 txn
Insider
Kohli Prashant
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 267,160 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 267,160 contracts (Direct)
Footnotes (1)
- F1. These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall vest immediately upon the grant date with the remaining 11/12 vesting equally over the following 11 quarters starting on the three-month anniversary of the grant date.
Key Figures
Stock options granted: 267,160 options
Exercise price: $2.12 per share
Underlying common shares: 267,160 shares
+3 more
6 metrics
Stock options granted
267,160 options
Grant to CEO Prashant Kohli on 2026-08-28
Exercise price
$2.12 per share
Conversion or exercise price for the granted stock options
Underlying common shares
267,160 shares
Shares of Grace Therapeutics common stock underlying the options
Expiration date
2036-08-27
Expiry of the granted stock options
Immediate vesting tranche
1/12 of options
Vests immediately on the grant date, per footnote
Remaining vesting schedule
11 quarterly installments
Remaining 11/12 of options vest over the following 11 quarters
Key Terms
Stock Option (Right to Buy), exercise price, vesting, grant date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 2.1200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"These options vest quarterly in substantially equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant date financial
"vest immediately upon the grant date with the remaining 11/12"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
What insider transaction did GRCE report for Prashant Kohli?
Grace Therapeutics reported that CEO and director Prashant Kohli received a grant of 267,160 stock options on 2026-08-28, giving him the right to buy 267,160 shares of common stock at an exercise price of $2.12 per share until 2036-08-27.
What is the exercise price of the new stock options granted by GRCE to its CEO?
The stock options granted to Grace Therapeutics CEO Prashant Kohli have an exercise price of $2.12 per share, allowing the purchase of up to 267,160 shares of the company’s common stock, subject to vesting and expiration on 2036-08-27.
How do the newly granted GRCE stock options to the CEO vest?
The options granted to Grace Therapeutics CEO Prashant Kohli vest over three years: 1/12 vested immediately on the grant date, and the remaining 11/12 vest in substantially equal quarterly installments over the next 11 quarters, contingent on his continuous service.
When do Prashant Kohli’s newly granted GRCE stock options expire?
The stock options granted to Prashant Kohli by Grace Therapeutics expire on 2036-08-27. Until that date, once vested, they allow him to purchase up to 267,160 shares of GRCE common stock at an exercise price of $2.12 per share.
How many GRCE stock options does the CEO hold after this grant?
After this award, Grace Therapeutics CEO Prashant Kohli holds 267,160 stock options associated with this specific grant, as reported as the total derivative securities following the transaction in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
